Clinical Trials Directory

Trials / Completed

CompletedNCT01051999

Glutamine Supplementation in Cystic Fibrosis

Glutamine Supplementation and Immunity in Adults With Cystic Fibrosis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with cystic fibrosis develop frequent and potentially life-threatening lung infections. Recent studies suggest that the nutrient "glutamine" may help the body fight off infection. Glutamine is an amino acid; a type of nutrient the body requires to build muscle. It is one of the building blocks of protein. During an illness, blood levels of glutamine tend to be lower than normal. Also, many patients with cystic fibrosis have difficulty getting normal levels of nutrients from food. The aim of this study is to see if patients with cystic fibrosis have low levels of glutamine when they experience an infection, and whether a dietary glutamine supplement taken daily for three months can raise these levels. We also want to see if this supplement can improve other blood markers of immunity (the body's ability to defend itself from infection). We hope to enroll 40 people with cystic fibrosis who experience a lung infection, over a one year period, into this study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlutamineOral glutamine powder
DIETARY_SUPPLEMENTL-alanineL-alanine oral powder

Timeline

Start date
2010-02-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2010-01-20
Last updated
2015-01-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01051999. Inclusion in this directory is not an endorsement.